These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial. Liu J; Nie X; Gu H; Zhou Q; Sun H; Tan Y; Liu D; Zheng L; Zhao J; Wang Y; Cao Y; Zhu H; Zhang Y; Yi L; Pu Y; Wen M; Yang Z; Sun S; Wang W; Zhao X; Liu L; Wang Y Stroke Vasc Neurol; 2021 Jun; 6(2):160-169. PubMed ID: 33795488 [TBL] [Abstract][Full Text] [Related]
7. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. WOMAN Trial Collaborators Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509 [TBL] [Abstract][Full Text] [Related]
8. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. HALT-IT Trial Collaborators Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378 [TBL] [Abstract][Full Text] [Related]
9. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. CRASH-3 trial collaborators Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894 [TBL] [Abstract][Full Text] [Related]
10. Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial. Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Bath PM; Sprigg N; Christensen H BMC Res Notes; 2018 Jun; 11(1):379. PubMed ID: 29895329 [TBL] [Abstract][Full Text] [Related]
11. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT. Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491 [TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial. Yassi N; Zhao H; Churilov L; Campbell BCV; Wu T; Ma H; Cheung A; Kleinig T; Brown H; Choi P; Jeng JS; Ranta A; Wang HK; Cloud GC; Grimley R; Shah D; Spratt N; Cho DY; Mahawish K; Sanders L; Worthington J; Clissold B; Meretoja A; Yogendrakumar V; Ton MD; Dang DP; Phuong NTM; Nguyen HT; Hsu CY; Sharma G; Mitchell PJ; Yan B; Parsons MW; Levi C; Donnan GA; Davis SM Stroke Vasc Neurol; 2022 Apr; 7(2):158-165. PubMed ID: 34848566 [TBL] [Abstract][Full Text] [Related]
14. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol. Jiang C; Wang J; Wang J; Zhang J; J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508 [TBL] [Abstract][Full Text] [Related]
15. Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign. Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Christensen LM; Overgaard K; Rasmussen RS; Bath PM; Sprigg N; Christensen H Stroke; 2021 Aug; 52(8):2629-2636. PubMed ID: 34000834 [TBL] [Abstract][Full Text] [Related]
16. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial. Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901 [TBL] [Abstract][Full Text] [Related]
17. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Selim M; Foster LD; Moy CS; Xi G; Hill MD; Morgenstern LB; Greenberg SM; James ML; Singh V; Clark WM; Norton C; Palesch YY; Yeatts SD; Lancet Neurol; 2019 May; 18(5):428-438. PubMed ID: 30898550 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial. Peter-Derex L; Philippeau F; Garnier P; André-Obadia N; Boulogne S; Catenoix H; Convers P; Mazzola L; Gouttard M; Esteban M; Fontaine J; Mechtouff L; Ong E; Cho TH; Nighoghossian N; Perreton N; Termoz A; Haesebaert J; Schott AM; Rabilloud M; Pivot C; Dhelens C; Filip A; Berthezène Y; Rheims S; Boutitie F; Derex L Lancet Neurol; 2022 Sep; 21(9):781-791. PubMed ID: 35963261 [TBL] [Abstract][Full Text] [Related]
19. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Post R; Germans MR; Tjerkstra MA; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; van de Vlekkert J; Bienfait HP; Boogaarts HD; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D; Lancet; 2021 Jan; 397(10269):112-118. PubMed ID: 33357465 [TBL] [Abstract][Full Text] [Related]
20. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]